Current methods for attaching targeting ligands to liposomes and nanoparticles.

Liposomes and nanoparticles have emerged as versatile carrier systems for delivering active molecules in the organism. These colloidal particles have demonstrated enhanced efficacy compared to conventional drugs. However, the design of liposomes and nanoparticles with a prolonged circulation time and ability to deliver active compounds specifically to target sites remains an ongoing research goal. One interesting way to achieve active targeting is to attach ligands, such as monoclonal antibodies or peptides, to the carrier. These surface-bound ligands recognize and bind specifically to target cells. To this end, various techniques have been described, including covalent and noncovalent approaches. Both in vitro and in vivo studies have proved the efficacy of the concept of active targeting. The present review summarizes the most common coupling techniques developed for binding homing moieties to the surface of liposomes and nanoparticles. Various coupling methods, covalent and noncovalent, will be reviewed, with emphasis on the major differences between the coupling reactions, on their advantages and drawbacks, on the coupling efficiency obtained, and on the importance of combining active targeting with long-circulating particles.

[1]  John W. Park,et al.  Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. , 1997, Biochemistry.

[2]  A. Gabizon,et al.  Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Jacques Barbet,et al.  Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A , 1980, Nature.

[4]  G. Storm,et al.  Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. , 1993, Biochimica et biophysica acta.

[5]  G. Weissmann,et al.  Interaction of immunoglobulins with liposomes. , 1974, The Journal of clinical investigation.

[6]  J. Kamps,et al.  Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine from immunoliposomes to colon cancer cells. , 1999, Biochimica et biophysica acta.

[7]  S. Zalipsky Synthesis of an end-group functionalized polyethylene glycol-lipid conjugate for preparation of polymer-grafted liposomes. , 1993, Bioconjugate chemistry.

[8]  F. Karush,et al.  Attachment of immunoglobulin to liposomal membrane via protein carbohydrate. , 1984, Biochimica et biophysica acta.

[9]  T M Allen,et al.  Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.

[10]  G. Storm,et al.  In vivo targeting of OV-TL 3 immunoliposomes to ascitic ovarian carcinoma cells (OVCAR-3) in athymic nude mice. , 1992, Cancer research.

[11]  E. Moase,et al.  Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures. , 1995, Biochimica et biophysica acta.

[12]  M. Bally,et al.  A non-covalent method of attaching antibodies to liposomes. , 1987, Biochimica et biophysica acta.

[13]  S. Kennel,et al.  Binding of immunoglobulin G to phospholipid vesicles by sonication. , 1979, Biochemistry.

[14]  F. Martin,et al.  Irreversible coupling of immunoglobulin fragments to preformed vesicles. An improved method for liposome targeting. , 1982, The Journal of biological chemistry.

[15]  S. Mao,et al.  Biotinylation of antibodies. , 1994, Methods in molecular biology.

[16]  V. Babaev,et al.  Liposome uptake by cultured macrophages mediated by modified low-density lipoproteins. , 1985, Biochimica et biophysica acta.

[17]  M. Akashi,et al.  Synthesis of polystyrene nanospheres having lactose-conjugated hydrophilic polymers on their surfaces and carbohydrate recognition by proteins. , 1999, Journal of biomaterials science. Polymer edition.

[18]  V. Torchilin,et al.  Comparative studies on covalent and noncovalent immobilization of protein molecules on the surface of liposomes. , 1978, Biochemical and biophysical research communications.

[19]  V. Torchilin,et al.  p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups. , 2001, Biochimica et biophysica acta.

[20]  P. Couvreur,et al.  Surface-engineered nanoparticles for multiple ligand coupling. , 2003, Biomaterials.

[21]  T. Nagai,et al.  Preparation and evaluation of bovine serum albumin nanospheres coated with monoclonal antibodies. , 1988, Drug design and delivery.

[22]  P. Couvreur,et al.  Isobutyl cyanoacrylate nanoparticles as a solid phase for an efficient immunoradiometric assay. , 1986, Biomaterials.

[23]  G. Adams,et al.  Monoclonal antibody therapy for cancer. , 2003, Annual review of medicine.

[24]  G. Scherphof,et al.  An improved method for the covalent coupling of proteins to liposomes , 1985 .

[25]  D. Pacchioni,et al.  Antitumoral activity of liposomes and immunoliposomes containing 5-fluorouridine prodrugs. , 1997, Journal of pharmaceutical sciences.

[26]  V. Torchilin,et al.  Characterization of in vivo immunoliposome targeting to pulmonary endothelium. , 1990, Journal of pharmaceutical sciences.

[27]  M. Ogris,et al.  Nanoparticles bearing polyethyleneglycol-coupled transferrin as gene carriers: preparation and in vitro evaluation. , 2003, International journal of pharmaceutics.

[28]  R. W. Baldwin,et al.  Adsorption of monoclonal antibodies to polyhexylcyanoacrylate nanoparticles and subsequent immunospecific binding to tumour cells in vitro , 1983 .

[29]  P. Jap,et al.  Design of immunoliposomes directed against human ovarian carcinoma. , 1995, Biochimica et biophysica acta.

[30]  J. Weinstein,et al.  Receptor-mediated endocytosis of antibody-opsonized liposomes by tumor cells. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[31]  H. Yanagie,et al.  Liposomes Bearing Polyethyleneglycol-Coupled Transferrin with Intracellular Targeting Property to the Solid Tumors In Vivo , 2001, Pharmaceutical Research.

[32]  T M Allen,et al.  In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma. , 1998, Cancer research.

[33]  V. Torchilin,et al.  Incorporation of hydrophilic protein modified with hydrophobic agent into liposome membrane. , 1980, Biochimica et biophysica acta.

[34]  Kazuo Maruyama,et al.  Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.

[35]  V. Torchilin,et al.  Biodegradable long-circulating polymeric nanospheres. , 1994, Science.

[36]  Allan G. A. Coombes,et al.  Surface Modification of Poly(lactide-co-glycolide) Nanospheres by Biodegradable Poly(lactide)-Poly(ethylene glycol) Copolymers , 1994, Pharmaceutical Research.

[37]  P. Steerenberg,et al.  Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo. , 1996, British Journal of Cancer.

[38]  Ulrik B Nielsen,et al.  Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[39]  Willis,et al.  Ligand-targeted liposomes. , 1998, Advanced drug delivery reviews.

[40]  S. P. Vyas,et al.  Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization. , 2001, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[41]  F. Martin,et al.  Immunospecific targeting of liposomes to cells: a novel and efficient method for covalent attachment of Fab' fragments via disulfide bonds. , 1981, Biochemistry.

[42]  J. Portnoy,et al.  Monoclonal antibody-based assay for Alt a1, a major Alternaria allergen. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[43]  Bally,et al.  Clearance properties of liposomes involving conjugated proteins for targeting. , 1998, Advanced drug delivery reviews.

[44]  V. Torchilin,et al.  Phosphatidylinositol may serve as the hydrophobic anchor for immobilization of proteins on liposome surface , 1982 .

[45]  L. Huang,et al.  Monoclonal antibody targeting of liposomes to mouse lung in vivo. , 1989, Cancer research.

[46]  V. Torchilin,et al.  Preservation of antimyosin antibody activity after covalent coupling to liposomes. , 1979, Biochemical and biophysical research communications.

[47]  J. Weinstein,et al.  Binding of antigen-bearing fluorescent liposomes to the murine myeloma tumor MOPC 315. , 1979, Journal of immunology.

[48]  M S Newman,et al.  Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes. , 1997, Biochimica et biophysica acta.

[49]  K. Maruyama,et al.  Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice. , 1999, International journal of pharmaceutics.

[50]  V. Torchilin,et al.  Poly(ethylene glycol)-coated anti-cardiac myosin immunoliposomes: factors influencing targeted accumulation in the infarcted myocardium. , 1996, Biochimica et biophysica acta.

[51]  Maruyama,et al.  Possibility of active targeting to tumor tissues with liposomes. , 1999, Advanced drug delivery reviews.

[52]  L. Huang,et al.  Highly efficient immunoliposomes prepared with a method which is compatible with various lipid compositions. , 1989, Biochemical and biophysical research communications.

[53]  R. Jain,et al.  Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[54]  S. Gupta,et al.  A three-step strategy for targeting drug carriers to human ovarian carcinoma cells in vitro. , 2002, Journal of biotechnology.

[55]  V. Torchilin,et al.  A new hydrophobic anchor for the attachment of proteins to liposomal membranes , 1986, FEBS letters.

[56]  P. Walther,et al.  Targeting of monoclonal antibody-coated liposomes to sheep red blood cells. , 1981, Biochemical and biophysical research communications.

[57]  C. Benz,et al.  Anti-HER2 immunoliposomes for targeted therapy of human tumors. , 1997, Cancer letters.

[58]  V. Torchilin,et al.  Intracytoplasmic gene delivery for in vitro transfection with cytoskeleton-specific immunoliposomes. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[59]  L. Delattre,et al.  Preparation of poly(D,L-lactide) nanoparticles assisted by amphiphilic poly(methyl methacrylate-co-methacrylic acid) copolymers , 2001, Journal of biomaterials science. Polymer edition.

[60]  D. Papahadjopoulos,et al.  Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. , 1999, Pharmacological reviews.

[61]  H von Briesen,et al.  Preparation of avidin-labeled protein nanoparticles as carriers for biotinylated peptide nucleic acid. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[62]  Alexander T. Florence,et al.  Enhanced Oral Uptake of Tomato Lectin-Conjugated Nanoparticles in the Rat , 1997, Pharmaceutical Research.

[63]  Robert Gurny,et al.  Surface modification of poly(lactic acid) nanoparticles by covalent attachment of thiol groups by means of three methods. , 2003, International journal of pharmaceutics.

[64]  Robert Gurny,et al.  Drug-loaded nanoparticles : preparation methods and drug targeting issues , 1993 .

[65]  R K Jain,et al.  Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. , 1995, Cancer research.

[66]  J. Irache,et al.  Preparation and characterization of lectin-latex conjugates for specific bioadhesion. , 1994, Biomaterials.

[67]  S. Ménard,et al.  Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[68]  V. Torchilin,et al.  Targeted accumulation of polyethylene glycol‐coated immunoliposomes in infarcted rabbit myocardium , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[69]  L. Huang,et al.  Monoclonal antibody covalently coupled with fatty acid. A reagent for in vitro liposome targeting. , 1980, The Journal of biological chemistry.

[70]  G. Scherphof,et al.  UPTAKE AND PROCESSING OF IMMUNOGLOBULIN-COATED LIPOSOMES BY SUBPOPULATIONS OF RAT-LIVER MACROPHAGES , 1988 .

[71]  John W. Park,et al.  Development of anti-p185HER2 immunoliposomes for cancer therapy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[72]  A. Maruyama,et al.  Nanoparticle DNA carrier with poly(L-lysine) grafted polysaccharide copolymer and poly(D,L-lactic acid). , 1997, Bioconjugate chemistry.

[73]  P. Volberding,et al.  Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's Sarcoma , 1996, Journal of clinical pharmacology.

[74]  J. Weinstein,et al.  Antibody-mediated targeting of liposomes. Binding to lymphocytes does not ensure incorporation of vesicle contents into the cells. , 1978, Biochimica et biophysica acta.

[75]  John W. Park,et al.  Immunoliposomes for cancer treatment. , 1997, Advances in pharmacology.

[76]  R. W. Baldwin,et al.  Tissue distribution of poly(hexyl 2-cyanoacrylate) nanoparticles coated with monoclonal antibodies in mice bearing human tumor xenografts. , 1984, The Journal of pharmacology and experimental therapeutics.

[77]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[78]  Y. Yarden,et al.  Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies. , 1996, British Journal of Cancer.

[79]  Douglas J. Goetz,et al.  Ligand Coated Nanosphere Adhesion to E- and P-Selectin under Static and Flow Conditions , 2001, Annals of Biomedical Engineering.

[80]  J. Petriz,et al.  A novel strategy affords high-yield coupling of antibody to extremities of liposomal surface-grafted PEG chains. , 1999, Biochimica et biophysica acta.

[81]  D. Barritault,et al.  Biotinylated basic fibroblast growth factor is biologically active. , 1991, Analytical biochemistry.

[82]  J. C. Domingo,et al.  Preparation of long-circulating immunoliposomes using PEG-cholesterol conjugates: effect of the spacer arm between PEG and cholesterol on liposomal characteristics. , 2001, Chemistry and physics of lipids.

[83]  G. Storm,et al.  ACTIVE TARGETING WITH PARTICULATE CARRIER SYSTEMS IN THE BLOOD COMPARTMENT , 1995 .

[84]  H. von Briesen,et al.  Preparation of avidin-labelled gelatin nanoparticles as carriers for biotinylated peptide nucleic acid (PNA). , 2000, International journal of pharmaceutics.

[85]  P. Meers,et al.  Enzyme-activated targeting of liposomes. , 2001, Advanced drug delivery reviews.

[86]  G. Fulci,et al.  Tumor cell targeting with antibody-avidin complexes and biotinylated tumor necrosis factor alpha. , 1997, Cancer research.

[87]  J. J. Moore,et al.  Specific interaction of myeloma tumor cells with hapten-bearing liposomes containing methotrexate and carboxyfluorescein. , 1980, Cancer research.

[88]  F. Martin CHAPTER 8.2 – Clinical pharmacology and antitumor efficacy of DOXIL (pegylated liposomal doxorubicin) , 1998 .

[89]  P. Working,et al.  Tissue distribution and therapeutic effect of intravenous free or encapsulated liposomal doxorubicin on human prostate carcinoma xenografts , 1994, Cancer.

[90]  F. Fazio,et al.  Quantitative comparison of direct antibody labeling and tumor pretargeting in uveal melanoma. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[91]  J M Irache,et al.  Preparation of Ulex europaeus lectin-gliadin nanoparticle conjugates and their interaction with gastrointestinal mucus. , 1999, International journal of pharmaceutics.

[92]  T. Allen,et al.  A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. , 1995, Biochimica et biophysica acta.

[93]  L. Huang,et al.  Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies. , 1995, Biochimica et biophysica acta.

[94]  J H Senior,et al.  Fate and behavior of liposomes in vivo: a review of controlling factors. , 1987, Critical reviews in therapeutic drug carrier systems.

[95]  P. Couvreur,et al.  Sorptive properties of antibodies onto cyanoacrylic nanoparticles , 1988 .

[96]  L. Huang,et al.  An improved method for covalent attachment of antibody to liposomes. , 1982, Biochimica et biophysica acta.

[97]  D. Bloomgarden,et al.  A general method for the introduction of enzymes, by means of immunoglobulin-coated liposomes, into lysosomes of deficient cells. , 1975, Proceedings of the National Academy of Sciences of the United States of America.